-ISO 9001:2000
   

Troydecyl Inj.:

Trodecyl (sodium tetradecyl sulfate injection) is a sterile nonpyrogenic solution for intravenous use as a sclerosing agent. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration.

   
- - -

       

Indication:
Troydecyl is indicated in the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves. The benefit-to-risk ratio should be considered in selected patients who are great surgical risks.

Dosage & Administration:
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration. Do not use if precipitated or discolored. Troydecyl is for intravenous use only.

   

The strength of solution required depends on the size and degree of varicosity. The 3% solution is preferred for larger varicosities.

The dosage should be kept small, using 0.5 to 2 ml (preferably 1 ml maximum) for each injection, and the maximum single treatment should not exceed 10 ml.

Availability:
3% solution 2 ml  ampoules

 
Media Releases:

Troikaa received the IDMA Patent Appreciation Award for the year 2009-2010. The prestigious award was conferred upon Troikaa for its innovative brand - Dynapar AQ 75mg/1ml Injection.

 
   
-

 
Corporate Philosophy
Troikaa Pharmaceuticals Limited is a young pharmaceutical company, which has acquired a reputation of an innovative company, over the years. We have been steadfastly sowing the basics of Innovation, Quality and Service to reap excellence.
 

Home | Company | Products | Technologies | International Business | Media Releases | Human Resources | Business Alliances | Research Publications

Copyright © 2009 Troikaa Pharmaceuticals Ltd. - Disclaimer